High Frequency and Intensive Prevention Program

January 4, 2023 updated by: University Hospital, Basel, Switzerland

High Frequency Multimodal Training Including Tai Chi for Improving Motor and Cognitive Function in People With Parkinson's Disease

The treatment of PD has made considerable advances in recent years with respect to drug therapies, as well as many new physiotherapy and drug-based methods, and there have also been great improvements in therapy thanks to deep brain stimulation. Cognitive rehabilitation has shown to be effective in PD (Abbruzzese et al., 2016), however, there has yet to be a major breakthrough in the treatment and prevention of PDD (Parkinson's Disease Dementia ). This is where the high frequency and intensive prevention described here comes into play.

Study Overview

Status

Completed

Conditions

Detailed Description

Cognitive decline is an important and common complication in Parkinson's Disease (PD); approximately 27% of non-demented PD patients have Mild Cognitive Impairment (MCI) (Litvan et al. 2012, Chaudhuri et al., 2011) and up to 80% develop PD dementia (PD-D) over the long term (Hely et al., 2005). Cognitive course in PD is heterogeneous and affects visuospatial, attentional, executive and memory function; studies report different cognitive subtypes and divergent patterns of cognitive decline (Kehagia et al., 2010; Litvan et al., 2011; Williams-Gray et al., 2007; Yarnall et al., 2014). Recently, models have been constructed to estimate individual risk for global cognitive impairment using a small set of predictor variables (Liu et al. 2017; Velseboer et al., 2016). These prediction algorithms were developed in large samples of PD patients and accurately forecast cognitive decline in both, patients with MCI and patients with PD-D and were successfully replicated in independent samples; a score with a predefined cut off point predicts dementia with high positive and negative predictive values (Liu et al., 2017).

The primary aim of this study is the possible stabilization or delay of cognitive decline as well as the improvement of the quality of life of the patients. As secondary outcome, the change in symptoms associated with PD, will be investigated. Psychological states as depression and anxiety, as well as cognitive performance in different areas, for example attention and memory shall be investigated. Neurological symptoms, for example motor function and sleepiness, will also be assessed as secondary parameters and potentially confounding factors.

This study is a 4 week non-randomized controlled trial with one intervention group (HIPP) and one control group (CogniPlus). Primary and secondary outcome measures are assessed at baseline and are repeated after the 4-week intervention period and at 6 month in a follow-up assessment. After 4 weeks there is an intermediate measurement consisting of the primary outcome measures.

The intervention group receives individualized program: the program will be tailored to the patient's needs, strengths and weaknesses, resulting from the initial assessment.

  1. Tai Chi - "Keep Moving" is an exercise programme for patients with movement disorders that explicitly utilizes the health aspect of Tai Chi movement teachings. Each session lasted 60 minutes and ended with a 10-minute meditation. The Tai Chi sessions in our study were carried out twice a week under the guidance of certified Tai Chi instructors. Details of this program can be found on the following website: https://taiji-therapie.ch/
  2. CogniFit® - is a online-based personalized cognition training program. This well-validated cognitive training improves attention, working memory, memory, executive function, and visual perceptual functions. Each session lasted 20 minutes and was applied 2-5 times per week based on the results of the baseline tests. The home-based approach took place under the supervision of a psychologist or a specially trained psychology student. The difficulty level was automatically adjusted by the program itself. Details of the program can be found on the following website: https://www.cognifit.com/.
  3. SpeechCare - (MoveApp) is a home-based approach for patients with Parkinson's disease. The training program uses automatic speech recognition (ASR) and thus can provide feedback on speech intelligibility. Each session lasted 12 minutes and was conducted 1-3 times per week based on the results of the baseline test of SpeechCare . The domestic approach took place under the supervision of a psychologist or a specially trained psychology student. The level of difficulty was manually adjusted as needed. Details of the program can be found on the following website: https://www.speechcare.de/.

The patients in the control group received a computer-assisted cognitive training program: CogniPlus (Schuhfried GmbH, Vienna, Austria). Each training session consisted of different tasks (Focused attention; working memory; planning and action skill; respons inhibition) that were performed for 10 Minutes each. Details of the program can be found on the following website: www.schuhfried.at. The training sessions were supervised by a psychologist or a specially trained student of psychology

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Basel, Switzerland, 4031
        • University Hospital Basel

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 86 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with idiopathic Parkinson syndrome according to United Kingdom Parkinson's Disease Brain Bank Criteria
  • mental competence to provide informed consent
  • able to understand German sufficiently

Exclusion Criteria:

  • Severe dementia (DMS-IV, mini mental Status (MMS) <24, moca test (MoCa) <21)
  • young onset Parkinson's disease (<18y)
  • other neurological or psychiatric diseases of the brain not related to PD
  • secondary parkinsonism
  • physical impairment hindering the adequate execution of the training
  • insufficient knowledge of German
  • pregnancy
  • Deep Brain Stimulation (DBS) is no exclusion criterion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High frequency and intensive prevention

High frequency and intensive prevention program

  1. Tai Chi
  2. CogniFit (cognitive training)
  3. SpeechCare (speech training)
This study is a 4 week non-randomized controlled trial (RCT)
Active Comparator: Control group (CogniPlus)
Computer-assisted cognitive training program
This study is a 4 week non-randomized controlled trial (RCT)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Episodic memory: California Verbal Learning Test (CVLT; Delis, Kramer, Ober, & Kaplan, 1987)
Time Frame: Before and after 4 weeks of training, After 6-month
This is a method that tests memory functions, including encoding, retrieval, and recognition processes. The task is to learn in five cycles a shopping list of 16 words assigned to four semantic categories (i.e. beverages, fruits, clothing, tools). As many words as possible should be enumerated after each cycle. The sum of the words stored in the 1-5 cycles is used as the encoding parameter.
Before and after 4 weeks of training, After 6-month
working memory: Corsi Block Test (Härtig et al., 2000)
Time Frame: Before and after 4 weeks of training, After 6-month

Corsi Block Test serve to evaluate the verbal and visual working memory. In the Corsi Block, the test person is presented with a board with irregularly arranged cubes. The task is to remember a sequence of tapped cubes and then to tap the cubes in the same sequence or later to follow the path shown in reverse order. Also with this test the difficulty increases, as the offered sequences become increasingly longer.

The total score for the Digit Span is the sum of 12 items, ranging from 0 (worst possible result) to 12 (best possible result).

The total score for the Corsi Block is the sum of 14 points in forward typing, ranging from 0 (worst score) to 14 (best symptoms) and the sum of 12 points in backward typing from 0 (worst score) to 12 (best symptoms).

Before and after 4 weeks of training, After 6-month
Visuo-construction: Rey-Osterrieth complex figure (Duley et al., 1993)
Time Frame: Before and after 4 weeks of training, After 6-month

The Rey-Osterrieth (ROCF) and Taylor (TCF) complex figure tests are widely used to assess visuospatial and constructional abilities as well as visual/non-verbal Memory (Marie-Pier Tremblay et al., 2015). The score ranging from 0 (worst possible result) to 36 (best possible result).

·

Before and after 4 weeks of training, After 6-month
Attention: Trail Making Test, part A (J. Perianez et al., 2007)
Time Frame: Before and after 4 weeks of training, After 6-month
Trail Making Test, part A serve to evaluate the attention
Before and after 4 weeks of training, After 6-month
Executive function (flexibility): Wisconsin Card Sorting test, number of errors (H.E. Nelson, 1976)
Time Frame: Before and after 4 weeks of training, After 6-month
Wisconsin Card Sorting test serve to evaluate the executive function
Before and after 4 weeks of training, After 6-month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Electroencephalogram (EEG)
Time Frame: Before and after 4 weeks of training, After 6-month
  1. EEG power in Delta; Theta; Alpha 1; Alpha 2; Beta.
  2. Brain Network Connectivity
Before and after 4 weeks of training, After 6-month
Near-infrared spectroscopy
Time Frame: Before and after 4 weeks of training, After 6-month
Detecting changes in blood hemoglobin concentrations associated with neural activity
Before and after 4 weeks of training, After 6-month
Unified Parkinson's Disease Rating Scale UPDRS Part III
Time Frame: Before and after 4 weeks of training, After 6-month

This is the standard scale used for grading severity of PD. (UPDRS) - Four Parts Higher score values represent a worse outcome.

Part I: Mentation, Behavior and Mood - 4 questions 1-4 Score range: 1-16; Part II: Activities of Daily Living - 13 questions 5-17 Score range: 0-52 Part III: Motor Examination - 19 questions 18-31 and 25 total assessments Score range: 0-100 Part IV: Complications of Therapy (In the past week) - 11 questions Score range: 0-25

Before and after 4 weeks of training, After 6-month
Tinetti Mobility Test (D.A. Kegelmeyer et al., 2007)
Time Frame: Before and after 4 weeks of training, After 6-month
Balance and stability assessment
Before and after 4 weeks of training, After 6-month
Epworth Sleepiness Scale (M.W. Johns, 1991)
Time Frame: Before and after 4 weeks of training, After 6-month
Measuring Daytime Sleepiness
Before and after 4 weeks of training, After 6-month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Peter Fuhr, Prof.Dr.med, University Hospital, Basel, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2020

Primary Completion (Actual)

November 1, 2021

Study Completion (Actual)

February 1, 2022

Study Registration Dates

First Submitted

September 17, 2019

First Submitted That Met QC Criteria

September 24, 2019

First Posted (Actual)

September 25, 2019

Study Record Updates

Last Update Posted (Estimate)

January 6, 2023

Last Update Submitted That Met QC Criteria

January 4, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson Disease

Clinical Trials on High frequency and intensive prevention program

3
Subscribe